3 results match your criteria: "Medical College of Pennsylvania and Hahneman University[Affiliation]"
Toxicol Appl Pharmacol
August 1999
Department of Pharmacology, Medical College of Pennsylvania and Hahneman University, 3200 Henry Avenue, Philadelphia, Pennsylvania, 19129, USA.
The effects of cocaine administration on cardiovascular parameters were studied in anesthetized nonpregnant and pregnant rabbits with no prior exposure to cocaine and in pregnant rabbits repeatedly administered cocaine (4 mg/kg, bid, iv) for 15-20 days prior to the experiment. Rabbits were instrumented to determine the effects of cocaine on blood pressure, heart rate, and organ blood flows. Administration of the 1 and 2 mg/kg doses of cocaine increased blood pressure and decreased heart rate in both pregnant and nonpregnant rabbits.
View Article and Find Full Text PDFArch Fam Med
February 1996
Department of Family Medicine, Medical College of Pennsylvania and Hahneman University, Philadelphia, USA.
Objective: To explore the emotional impact of the most memorable mistake on family physicians, the support they needed and received, and their response to a hypothetical scenario in which a colleague's decision was associated with a fatal outcome.
Setting And Participants: Randomly selected members of a county chapter of a midwestern state academy of family physicians.
Design: Qualitative cross-sectional survey using in-depth interviews subject to content analysis.
Am J Psychiatry
May 1995
Department of Psychiatry, Medical College of Pennsylvania and Hahneman University, Philadelphia 19129, USA.
Objective: The authors sought to determine whether fluphenazine dose or plasma level predicts clinical improvement or side effects during acute treatment.
Method: Oral fluphenazine was given in fixed, randomized, double-blind doses (10, 20, or 30 mg/day) for 4 weeks to 72 inpatients with acute schizophrenic exacerbations. Outcome measures included percentage improvement in ratings of positive symptoms (hallucinations, delusions, and thought disorder), percentage improvement in negative symptoms, and maximum score for extrapyramidal symptoms.